sales@reportocean.com (Bussiness Sales)
+18882123539 (Us - Toll Free)
+919997112116 (Rest Of World)
Global Cancer Diagnostics Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024

Global Cancer Diagnostics Market Analysis, Companies Profiles, Size, Share, Growth,...

Home / Categories / Healthcare
Global Cancer Diagnostics Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024
Global Cancer Diagnostics Market Analysis,...
Report Code
RO1/110/1372

Publish Date
01/Jun/2017

Pages
350
PRICE
$ 1800/-
This is a single user license, allowing one specific user access to the product. The product is a PDF.
$ 2850/-
This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF..
In this region, Global cancer diagnostics is projected to reach USD 40.10 billion by 2024 from USD 16.55 billion in 2016, at a CAGR of 11.7% in the forecast period 2017 to 2024.
The major factors driving the growth of this market are the growing aging population worldwide, government initiatives for funding, and awareness about cancer.

The key market players for Global Cancer Diagnostics Market are listed below;

GE Healthcare
Siemens Healthcare
GmbH
Hologic, Inc,
Becton,
Dickinson and Company
Thermo Fisher Scientific, Inc.
Illumina, Inc.
Roche Diagnostics,
Abbott,
QIAGEN.
The market is further segmented into;
Type
Application
Technology
End User
Geography

The global cancer diagnostics market is segmented on the basis of technology, application, and geography. The global cancer diagnostics market is segmented into two types, platform based and instrument based. In 2017, the cancer diagnostics instrument based segment is expected to dominate the market with a share of 68.8% and is expected to continue this trend till 2024.
Cancer diagnostics platform based market is segmented into polymerase chain reaction (PCR), in situ hybridization (ISH), immunohisto chemistry (IHC), next generation sequencing (NGS), DNA microarrays, flow cytometry and others. Cancer Diagnostics instrument based market is segmented into imaging and biopsy. Imaging is further segmented into magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography- computed tomography (PET-CT), mammography, and ultrasound.
On the basis of application, the market is segmented into lung cancer, breast cancer, colorectal cancer, melanoma and others.
Based on geography, the Global cancer diagnostics market is segmented into 11 geographical regions, such as,

North America,
Europe,
Asia-Pacific,
Latin America,
Rest of the World

Covered in this report
The report covers the present scenario and the growth prospects of the Global cancer diagnostics market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.
You can request one free hour of our analyst?s time when you purchase this market report. Details are provided within the report.




OUR CLIENTS

500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES
+18882123539
sales@reportocean.com